Coronavirus / COVID

Latest News

FDA Approves Novavax COVID-19 Vaccine
FDA Approves Novavax COVID-19 Vaccine

May 19th 2025

The company's Nuvaxovid vaccine is the only recombinant protein-based, non-mRNA COVID-19 immunization available in the US.

Investigational Long COVID Therapy Enrolls First Phase 2 Participant
Investigational Long COVID Therapy Enrolls First Phase 2 Participant

May 15th 2025

Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations
Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations

May 7th 2025

 New Long COVID-19 Research Identifies Biomarkers, Immune Networks, and Cognitive Therapy
New Long COVID-19 Research Identifies Biomarkers, Immune Networks, and Cognitive Therapy

May 5th 2025

FDA Asks for More Data for Moderna’s Influenza COVID-19 Combination Vaccine
FDA Asks for More Data for Moderna’s Influenza COVID-19 Combination Vaccine

May 2nd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.